General Information
The Journal of Bursa Faculty of Medicine (J Bursa Med) is an international, peer-reviewed, open-access medical journal that publishes high-quality scientific research in all fields of basic, clinical, and translational medicine and health sciences.
The Journal publishes original articles, review articles, case reports, short communications, letters to the editor, editorials, and other scholarly contributions that are scientifically rigorous, ethically conducted, and relevant to the scope of the Journal.
Manuscripts submitted to the Journal must be original, must not have been published previously, and must not be under consideration for publication elsewhere.
Detailed information regarding the Journal's editorial policies, peer-review process, publication ethics, and open access policy is available in the relevant sections of the Journal website.
Institutional Review Board (IRB) / Ethics Committee Approval
Studies involving human participants or animals must comply with the Journal's Publication Ethics and Editorial Policies.
Authors must report the name of the approving Ethics Committee/IRB, the approval number, and the approval date in the Materials and Methods section, where applicable.
Clinical trials should include the registry name and registration number.
Detailed ethical requirements are available in the Journal's Publication Ethics and Editorial Policies.
Copyright and Licensing Agreement
Authors are required to complete the Journal's Copyright and Licensing Agreement form (📝 Copyright License and Agreement_V1.1.docx ) during manuscript submission.
By submitting a manuscript, the corresponding author confirms that:
- the manuscript is original;
- it has not been published previously and is not under consideration elsewhere;
- all authors have approved the submission;
- permission has been obtained for any copyrighted material included in the manuscript.
All published articles are licensed in accordance with the Journal's current Creative Commons licensing policy. Detailed information regarding copyright ownership and licensing is available on the Journal website.
Conflict of Interest
All authors must disclose any financial or non-financial conflicts of interest that could influence the work reported in the manuscript.
A Conflict of Interest Statement must be included in the manuscript at the time of submission, even if the authors declare that no conflict of interest exists.
Authors are required to complete the Journal's Conflict of Interest Disclosure Form (📝 Conflict of Interest Disclosure Form v1.0.docx ) during manuscript submission.
Any relationships, affiliations, funding, or personal interests that could be perceived as influencing the research should be disclosed.
Detailed information regarding the Journal's conflict of interest policy is available in the Ethical Principles and Publication Policy.
Manuscript Submission
Manuscripts must be submitted electronically through the DergiPark Journal System.
Authors are responsible for ensuring that all required files and documents are uploaded during submission.
Submitted manuscripts must comply with the Journal's formatting requirements, reporting guidelines, and publication policies.
The Editorial Office may return incomplete submissions to the corresponding author before peer review.
Authorship
Authorship should be based on substantial contributions to the conception or design of the study, data acquisition, analysis or interpretation, drafting or critically revising the manuscript, and final approval of the version to be published.
All authors must approve the submitted manuscript and agree to be accountable for the accuracy and integrity of the work.
Authors are required to complete the Journal's Authorship Contributions Form (📝 Authorship Contributions Form_v1.0.docx ) during manuscript submission.
Individuals who contributed to the study but do not meet the criteria for authorship should be acknowledged in the Acknowledgments section.
Detailed authorship criteria and policies are available in the Journal's Ethical Principles and Publication Policy.
Permission
Authors are responsible for obtaining written permission to reproduce any previously published copyrighted material, including tables, figures, photographs, illustrations, questionnaires, or other copyrighted content.
Appropriate acknowledgment of the original source must be provided in the manuscript.
Any fees associated with obtaining copyright permission are the responsibility of the authors.
Original Articles
Manuscript Preparation
Manuscripts should be prepared in an editable Microsoft Word (.doc or .docx) format.
The manuscript should be typed in Times New Roman, 12-point font, double-spaced, with 2.5 cm margins on all sides. Pages should be numbered consecutively.
The manuscript should be organized according to the Journal's requirements for the relevant article type. Authors are responsible for ensuring that the manuscript complies with the Journal's formatting and reporting standards before submission.
Abstract
Original Articles must include a structured abstract consisting of the following sections: Objective, Methods, Results, and Conclusion.
Review Articles, Case Reports, Short Communications, and Letters to the Editor should include an unstructured abstract unless otherwise specified.
The abstract should accurately summarize the content of the manuscript and should not contain references, tables, figures, or undefined abbreviations.
Keywords
Authors should provide 3–6 keywords immediately after the abstract.
Keywords should be selected from the Medical Subject Headings (MeSH) maintained by the U.S. National Library of Medicine whenever applicable.
Main Document Structure
The main manuscript should be arranged in the following order:
- Title
- Running Title
- Abstract
- Keywords
- Main Text
- Declarations (where applicable), including Author Contributions, Conflict of Interest, Funding, Data Availability, Ethics Committee Approval.
- Acknowledgments
- References
- Tables
- Figure Legends
Main Text
Original Articles should be organized under the following headings:
- Introduction
- Materials and Methods
- Results
- Discussion
- Conclusion
Standard abbreviations may be used after their first definition in the text. Generic names should be used for drugs and chemicals. Units of measurement should conform to the International System of Units (SI).
Headings and Subheadings
Use a maximum of three levels of headings throughout the manuscript. Headings should be concise, consistent, and clearly reflect the structure of the manuscript.
Footnotes
Footnotes should be used only when essential and should not be used for references. They should be numbered consecutively and placed at the bottom of the relevant page or table.
Acknowledgments
Individuals who contributed to the study but do not meet the criteria for authorship should be acknowledged in this section.
Authors should also acknowledge funding sources, technical assistance, institutional support, and any necessary permissions.
References
References should be prepared in accordance with the Recommendations of the International Committee of Medical Journal Editors (ICMJE), following the National Library of Medicine (NLM) / Vancouver reference style.
References should be numbered consecutively in the order in which they first appear in the text and cited using Arabic numerals in square brackets.
In-text citations should be formatted as follows:
Single reference:
... has been demonstrated [1].
Multiple references:
... has been previously reported [1,3,5].
Consecutive references:
... has been demonstrated in several studies [1–5].
Journal titles should be abbreviated according to the Index Medicus/PubMed journal abbreviations.
Authors are responsible for the accuracy and completeness of all references.
DOI numbers should be provided for all references whenever available.
Examples of commonly used reference formats are provided below.
Journal Article (Up to 6 Authors)
1. Duman N, Sen Korkmaz N, Erol Z. Tissue eosinophilia: a histopathological marker associated with stromal invasion but not histopathological grade in cutaneous squamous neoplasia. Eur Res J. 2015;1(3):88-93. doi:10.18621/eurj.2015.1.3.88
Journal Article (More than 6 Authors)
2. Budak E, Taymur I, Askin R, Gungor BB, Demirci H, Akgul AI, et al. Relationship between internet addiction, psychopathology and self-esteem among university students. Eur Res J. 2015;1:128-35.
Book Chapter
3. Vinten-Johansen J, Zhao ZQ, Guyton RA. Cardiac surgical physiology. In: Cohn LH, Edmunds LH Jr, editors. Cardiac Surgery in the Adult. 2nd ed. New York: McGraw-Hill; 2003. p. 53-84.
Website
4. University of Alabama School of Medicine. Interagency Registry for Mechanical Circulatory Support.
Available from: https://www.uab.edu/intermacs Accessed 2012 Apr 13.
Tables
Tables should be created using the table function of Microsoft Word and placed after the References section.
Tables should be numbered consecutively using Arabic numerals and cited in the text in numerical order.
Each table must have a concise title, and any abbreviations or explanatory notes should be provided as footnotes below the table.
Figures
Figures should be numbered consecutively using Arabic numerals and cited in the text in numerical order.
Figures should be uploaded as separate high-resolution files during submission.
Acceptable file formats are TIFF, JPEG, or PNG, with a minimum resolution of 300 dpi.
Authors are responsible for obtaining permission to reproduce previously published figures.
Figure Legends
Figure legends should be listed at the end of the manuscript after the figures.
Legends should clearly explain all symbols, abbreviations, arrows, and other annotations used in the figures.
Patient identifiers must not appear in figures unless written informed consent has been obtained.
Supplementary Materials
Supplementary materials may include additional tables, figures, methods, appendices, or other supporting information that complements the main manuscript but is not essential to its primary presentation.
All supplementary materials must be cited in the main text in numerical order (e.g., Supplementary Table S1, Supplementary Figure S1).
Supplementary tables and figures should be numbered independently from those in the main manuscript. For example, tables in the main manuscript should be numbered as Table 1, Table 2, etc., whereas supplementary tables should be numbered as Supplementary Table S1, Supplementary Table S2, etc.
Each supplementary item should have a clear title or caption and should be understandable independently of the main manuscript. Abbreviations and other necessary explanatory information should be provided.
Supplementary materials should be submitted as separate files and should not be embedded in the main manuscript unless specifically requested by the Editorial Office.
Authors are responsible for ensuring that all supplementary files cited in the manuscript are included in the submission and correspond to the version approved for publication.
Case Reports
Manuscript Preparation and Formatting
Case Reports must be submitted in an editable Microsoft Word (.doc or .docx) format. The manuscript should be typed in Times New Roman, 12-point font, double-spaced, with 2.5 cm margins on all sides. Pages should be numbered consecutively.
The manuscript should follow the structure and requirements specified for Case Reports in these Instructions for Authors. Authors are responsible for ensuring that their submissions comply with the Journal's formatting and reporting standards before submission.
Word and Reference Limits
The main text should not exceed 2,500 words. The abstract should not exceed 300 words. A maximum of 30 references and 10 tables and figures combined is permitted.
Manuscript Structure
Case Reports should be organized under the following headings:
- Introduction
- Case Presentation
- Discussion
- Conclusion
Abstract
Case Reports must include an unstructured abstract of no more than 300 words. The abstract should briefly summarize the clinical presentation, diagnostic findings, management, and main clinical message. It should accurately reflect the content of the manuscript and should not contain references, tables, figures, or undefined abbreviations.
Keywords
Authors should provide 3–6 keywords immediately after the abstract. Keywords should be selected from the Medical Subject Headings (MeSH) maintained by the U.S. National Library of Medicine whenever applicable.
Introduction
The Introduction should briefly describe the clinical background, explain the relevance of the case, and highlight its novelty or educational value.
Case Presentation
The Case Presentation section should provide a clear and chronological description of the patient's relevant medical history, clinical presentation, physical examination findings, diagnostic assessment, therapeutic interventions, and clinical outcomes, as applicable. Only information relevant to the case should be included, and patient confidentiality must be maintained throughout the manuscript.
Discussion
The Discussion should explain the clinical significance and distinctive features of the case, compare the findings with relevant literature, and highlight the principal diagnostic or therapeutic challenges and lessons for clinical practice. Claims regarding the novelty of the case should be supported by relevant literature.
Conclusion
The Conclusion should briefly summarize the main clinical message and its relevance to clinical practice. It should not introduce new information that has not been discussed in the manuscript.
Patient Consent and Confidentiality
Written informed consent for publication must be obtained from the patient or the patient's legally authorized representative, as applicable. The consent form must be submitted separately from the manuscript. Patient-identifying information must be removed from the manuscript, tables, figures, and supplementary materials. Images or other materials that could identify the patient may be published only when appropriate consent has been obtained.
Declarations
Authors should include all applicable declarations, including Author Contributions, Conflict of Interest, Funding, Data Availability, and Ethics Committee Approval or a statement regarding its applicability, as appropriate. Ethical requirements should be addressed in accordance with applicable institutional policies and regulations.
Tables and Figures
Tables, figures, and figure legends should be prepared according to the instructions provided in the Original Articles section of these Instructions for Authors. Authors should refer to that section for detailed requirements regarding formatting, numbering, in-text citations, file formats, resolution, figure legends, and patient confidentiality.
A maximum of 10 tables and figures combined is permitted for Case Reports.
References
References should be prepared according to the instructions provided in the Original Articles section of these Instructions for Authors. Authors should refer to that section for the applicable reference formatting and citation style requirements.
Review Article
Manuscript Preparation and Formatting
Review Articles must be submitted in an editable Microsoft Word (.doc or .docx) format. The manuscript should be typed in Times New Roman, 12-point font, double-spaced, with 2.5 cm margins on all sides. Pages should be numbered consecutively.
The manuscript should comply with the Journal's formatting and reporting requirements. Authors should refer to the Original Articles section of these Instructions for Authors for the general requirements regarding references, tables, figures, and figure legends.
Word and Reference Limits
The main text should not exceed 7,000 words. The abstract should not exceed 350 words. A maximum of 100 references and 15 tables and figures combined is permitted.
Manuscript Structure
Review Articles should be organized logically, with appropriate headings and subheadings according to the subject and scope of the review. The manuscript should provide a comprehensive and critical synthesis of the relevant literature, identify important developments and knowledge gaps, and discuss the implications for clinical practice and future research, as appropriate.
Systematic reviews and meta-analyses should follow the relevant reporting guidelines, including the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, where applicable.
Abstract
Review Articles must include an unstructured abstract of no more than 350 words. The abstract should summarize the background and purpose of the review, the main findings, and the overall conclusions. It should accurately reflect the content of the manuscript and should not contain references, tables, figures, or undefined abbreviations.
Keywords
Authors should provide 3–6 keywords immediately after the abstract. Keywords should be selected from the Medical Subject Headings (MeSH) maintained by the U.S. National Library of Medicine whenever applicable.
References, Tables, and Figures
References, tables, figures, and figure legends should be prepared according to the instructions provided in the Original Articles section of these Instructions for Authors.
Letters to the Editor
Manuscript Preparation and Formatting
Letters to the Editor must be submitted in an editable Microsoft Word (.doc or .docx) format. The manuscript should be typed in Times New Roman, 12-point font, double-spaced, with 2.5 cm margins on all sides. Pages should be numbered consecutively.
The manuscript should comply with the Journal's formatting requirements. Authors should refer to the Original Articles section of these Instructions for Authors for the general requirements regarding references, tables, figures, and figure legends.
Word and Reference Limits
The main text should not exceed 1,000 words. An abstract is not required. A maximum of 10 references and 5 tables and figures combined is permitted.
Content and Structure
Letters to the Editor may address articles recently published in the Journal or discuss relevant scientific, clinical, or methodological issues within the Journal's scope.
Letters commenting on previously published articles should clearly identify the article being discussed and provide constructive, evidence-based comments. Letters addressing broader scientific or clinical issues should present a clear central argument supported by relevant evidence.
Letters should be concise, focused, and written in a professional and respectful manner. Personal criticism should be avoided. The Editorial Board may invite the authors of the original article to submit a response.
References, Tables, and Figures
References, tables, figures, and figure legends should be prepared according to the instructions provided in the Original Articles section of these Instructions for Authors. The total number of tables and figures combined must not exceed 5.
Manuscript Categories and General Limits
The Journal considers the following manuscript types for publication. The limits below are provided as general guidance.
| Type of manuscript | Word limit | Abstract word limit | Reference limit | Table and figure total limit |
| Original Article | 5000 | 350 | 50 | 10 |
| Review Article | 7000 | 350 | 100 | 15 |
| Case Report | 2500 | 300 | 30 | 10 |
| Letter to the Editor | 1000 | No abstract | 10 | 5 |
These limits serve as general recommendations and may be adjusted at the discretion of the Editorial Board.
Unless otherwise specified, the main text word limit excludes the title, abstract, keywords, references, tables, figures, and figure legends. The abstract word limit applies separately to the abstract. For Letters to the Editor, no abstract is required.
Authors should also follow the specific formatting and structural requirements for their respective manuscript categories, as outlined in the relevant sections of these Instructions for Authors
Multicenter Clinical Trials
Manuscripts reporting multicenter clinical trials are welcome.
The corresponding author is responsible for ensuring that all contributors meet the Journal's authorship requirements and that all participating investigators are appropriately acknowledged.
Proofreading
Page proofs will be sent to the corresponding author before publication.
Authors should carefully review the proofs for typographical or production errors.
Major changes affecting the scientific content, authorship, or title are not permitted after acceptance without editorial approval.
Content Responsibility
The authors are solely responsible for the scientific accuracy, integrity, and content of their manuscripts.
Opinions expressed in published articles are those of the authors and do not necessarily reflect the views of the Editorial Board or the Publisher.
Artificial Intelligence (AI)-Assisted Technologies
AI Policy
The Journal encourages the transparent and responsible use of AI-assisted technologies in accordance with internationally accepted publication ethics principles.
The following policy applies to all manuscript types submitted to the Journal.
Authors must disclose any use of AI-assisted technologies in the preparation of the manuscript. The disclosure should specify the name and version of the AI tool(s), the purpose of use, and the sections of the manuscript in which AI assistance was used.
AI-assisted technologies may be used for language editing, grammar improvement, translation, literature organization, formatting, or similar editorial assistance. However, AI tools must not be used to generate, manipulate, fabricate, or falsify scientific data, images, results, references, or conclusions.
AI tools do not qualify for authorship and must not be listed as authors or co-authors. Authors remain fully responsible for the accuracy, originality, integrity, and appropriateness of all submitted content.
Authors should avoid uploading confidential, unpublished, or identifiable research data to publicly available AI platforms unless appropriate safeguards are in place.
Failure to disclose the substantial use of AI-assisted technologies may be considered a breach of the Journal's publication ethics and may result in editorial action.
The AI Disclosure statement should be included in the Declarations section of the manuscript.
Examples of AI Disclosure Statements
Example 1 – Language editing
Artificial Intelligence (AI) Disclosure
The authors used ChatGPT (OpenAI) solely for language editing and improving grammar and readability. All scientific content, interpretation, and conclusions were developed and verified by the authors, who take full responsibility for the final manuscript.
Example 2 – Literature organization
Artificial Intelligence (AI) Disclosure
The authors used Claude (Anthropic) to assist in organizing the literature and improving the structure of the manuscript. The authors independently verified all information and remain fully responsibility for the final content.
Example 3 – No AI
Artificial Intelligence (AI) Disclosure
If no AI-assisted technologies were used, no AI Disclosure statement is necessary
Example 4 – Figure or Graphical Abstract Preparation
Artificial Intelligence (AI) Disclosure
Artificial intelligence-assisted software was used solely to prepare figures and/or the graphical abstract of this manuscript. The scientific content, interpretation, and accuracy of all visual materials were reviewed and approved by the authors, who assume full responsibility for the final version.
Example 5 – Translation
Artificial Intelligence (AI) Disclosure
ChatGPT (OpenAI) was used to improve the English language and assist with translation. The authors reviewed and edited all AI-generated text and remain fully responsible for the final manuscript.
Example 6 – Statistical programming
Artificial Intelligence (AI) Disclosure
ChatGPT (OpenAI) was used to assist in generating R/Python code for statistical analyses. All statistical analyses were independently verified, executed, interpreted, and reported by the authors, who remain fully responsible for the reported results and conclusions.
The Editor-in-Chief or the handling editor may request additional information regarding the use of AI-assisted technologies whenever deemed necessary during the editorial evaluation process.
Submission Preparation Checklist
Before submitting your manuscript, please ensure that all of the following requirements have been completed:
□ The manuscript is original and has not been published previously.
□ The manuscript is not under consideration by another journal.
□ All authors have read and approved the submitted version.
□ The manuscript complies with the Journal's Instructions for Authors.
□ The manuscript complies with the Journal's Publication Ethics and Editorial Policies.
□ The main manuscript file has been fully anonymized for double-anonymized peer review.
□ A separate Title Page has been prepared.
□ Full author information has been provided on the Title Page.
□ ORCID iDs have been provided for all authors, where available.
□ A corresponding author has been designated.
□ Author Contributions have been prepared.
□ A Conflict of Interest Statement has been included.
□ Funding information has been provided.
□ A Data Availability Statement has been included, where applicable.
□ Ethics Committee approval information has been provided, where applicable.
□ Written informed consent has been obtained, where applicable.
□ Clinical trial registration information has been provided, where applicable.
□ Reporting guideline checklists (CONSORT, PRISMA, STROBE, CARE, ARRIVE, STARD, etc.) have been prepared, where applicable.
□ Artificial Intelligence (AI) use has been disclosed, where applicable.
□ References have been checked for completeness and accuracy.
□ DOI numbers have been included whenever available.
□ Tables have been cited in the text.
□ Figures have been cited in the text.
□ Figure legends have been provided.
□ Permissions have been obtained for previously published material.
□ Supplementary files have been cited in the manuscript, where applicable.
□ Supplementary materials should be submitted as separate files.
□ The manuscript has been reviewed for English language quality.
□ The completed Copyright & License Agreement has been uploaded as a separate file..
□ The completed Author Declaration Form has been uploaded as a separate file.
□ All required files have been uploaded to the online submission system.
□ All references have been verified against the original sources.
□ The corresponding author accepts responsibility for communication throughout the editorial and publication process.
Failure to comply with these requirements may result in the manuscript being returned to the corresponding author for technical revision before peer review.
